Jesse Shearin

Enterprise Ventures Group Ltd. provides financing services to small businesses in England and Wales. It offers venture capital, growth capital, and loans to small and medium enterprises. The company was founded in 2001 and is headquartered in Preston, the United Kingdom.

Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom.

Part of Mercia Asset Management Plc, Mercia Investments Ltd. provides investment services. The company is based in Henley-in-Arden, UK. Founded in 2014.

Calculus Capital Ltd (Calculus Capital) is a private equity and venture capital founded in 1999 by Susan R. McDonald and Arthur J. Glencross. The firm is headquartered in London, United Kingdom.

Part of Grant Thornton International Ltd., Grant Thornton (NI) LLP is a British professional services company. The company is based in Belfast, UK. The company was founded in 2014. Richard Gillan has been the CEO of the company since 2014.

Radnor Capital Partners Ltd. is a British UK-based company that provides clear, unconflicted advice across the capital markets spectrum. The private company bridges the gap between companies and capital by providing advice on investor targeting, messaging, market positioning, investor feedback, IPOs, presentations, and best practice. Radnor Capital Partners engages investors of all shapes and sizes, including large institutions, small institutions, pension funds, discretionary private wealth, advisory wealth, and family offices. Radnor Capital Partners has subsidiaries in the United Kingdom. The company was founded in 2016 by Joshua James Dexter Cryer.

Boobybiome Ltd. operates as a British biotechnology company.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

Part of Samson Eignarhaldsfélag ehf, Teathers Ltd. is a British company that provides securities brokerage services. The company is based in London, UK.

Oxford Genetics Ltd. produces modular DNA plasmids for biological research. Its products include DNA systems, kits, and cell lines. The company was founded by Ryan Cawood and Leonard Seymour on April 28, 2011 and is headquartered in Oxford, the United Kingdom.

Part of Sysmex Corp., Oxford Gene Technology (Operations) Ltd. is a holding British company that operates subsidiaries which develop, manufacture, and market molecular genetics. The company is based in Begbroke, UK and was founded in 1999.

Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Fluidic Analytics Ltd. develops proprietary technology to characterize proteins. The company was founded by Tuomas Knowles in 2013 and is headquartered in Cambridge, the United Kingdom.

Grant Instruments (Cambridge) Ltd. manufactures and designs life sciences and data acquisition products. It offers equipment for sample preparation, scientific analysis, data acquisition and data analysis providing solutions to the global scientific and industrial markets. The firm’s products include heating circulators, heated circulating baths, refrigerated circulating baths, unstirred water baths, centrifuges and shaker-incubators. The company was founded by Peter Ward and Cecil Chapman in 1952 and is headquartered in Shepreth, the United Kingdom.

Part of Sysmex Corp., Oxford Gene Technology IP Ltd. is a British company that engages in research and experimental development on biotechnology. The company is based in Begbroke, UK.

Cytocell Technologies Ltd. develops medical diagnostic solutions and services. It offers DNA screening solutions for detection of human genetic diseases in cytogenetics and cancer. The company was founded in 1991 by Bruce Savage and is headquartered in Cambridge, UK

Genome Diagnostics BV develops and markets vitro diagnostic tests and services, analysis software & education. Its products include NGSengine, SBTexcellerator, AlleleSEQR and SBTengine. The company was founded by Martijn Rozemuller, Wietse Mulder, Oscar Schoots, and Raoul Linschoten in March 2005 and is headquartered in Utrecht, the Netherlands.

Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts.

PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom.

GenDx, Inc. provides healthcare services. The private company is based in New York, NY.

nanoTherics Ltd. develops and manufactures magnetic nanoparticle-based products. Its product range includes devices and reagents for magnet assisted transfection and delivery of biomaterials into cells for the life science research and development market as well as products for nanoparticle heating applications. The company was founded by Jon Dobson and Neil Farrow in 2007 and is headquartered in Newcastle-under-Lyme, the United Kingdom.

Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK.

West Midlands Enterprise Ltd. operates as an alternative investment manager. It provides IT and business consultancy services. The company was founded in 1982 and is headquartered in Solihull, the United Kingdom.

Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage.

The Native Antigen Co. Ltd. develops viral vectors technologies. Its products include bacterial antigens, protozoal, and viral antigens. The company was founded by Nick Roesen and Andrew Maxwell in 2010 and is headquartered in Oxford, the United Kingdom.

Mercia Fund Management Ltd. (Mercia Fund) is a private equity subsidiary of Mercia Asset Management Plc founded in 1999 by Mark Andrew Payton, Timothy R. Hazell and Everard Mascarenhas. The firm is headquartered in Warwickshire, Great Britain.

Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.